FOXA
62
-2
PPL
72
2
CAT
51
-3
HOG
45
2
DIS
69
-9
WU
36
-4
GME
83
-3
HAL
41
-2
HES
40
-3
KEY
68
8
GOOGL
47
-11
NEE
67
-3
CVX
28
-4
COST
53
3
NI
78
3
LEG
50
-4
OXY
48
-2
DGX
59
9
ABBV
55
2
INTU
74
2
FOXA
62
-2
PPL
72
2
CAT
51
-3
HOG
45
2
DIS
69
-9
WU
36
-4
GME
83
-3
HAL
41
-2
HES
40
-3
KEY
68
8
GOOGL
47
-11
NEE
67
-3
CVX
28
-4
COST
53
3
NI
78
3
LEG
50
-4
OXY
48
-2
DGX
59
9
ABBV
55
2
INTU
74
2
Financhill
Back

Amneal Pharmaceuticals 10K Form

Buy
54

AMRX
Amneal Pharmaceuticals

Last Price:
$7.47
Seasonality Move:
4.85%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AMRX News And Ratings

See the #1 stock for the next 7 days that we like better than AMRX

AMRX Financial Statistics

Sales & Book Value

Annual Sales: $2.8B
Cash Flow: $-10.9M
Price / Cash Flow: 10.14
Annual Sales: $-0.42
Price / Book: 5.62

Profitability

EPS (TTM): -0.04050
Net Income (TTM): $-13M
Gross Margin: $1B
Return on Equity: -587.3%
Return on Assets: -0.38%

Amneal Pharmaceuticals Earnings Forecast

Key Amneal Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 9 years for AMRX is 36.52%.
  • The Selling, General & Administrative Expenses for AMRX have been equal to 17.05% of Gross Profit Margin.
  • The Research & Development expenses have been 7.04% of Revenue.
  • The Net Earning history of AMRX is -4.18% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 3 years.

Amneal Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: AMRX
CUSIP: 03168L
Website: amneal.com

Debt

Debt-to-Equity Ratio: -18.8
Current Ratio: 1.4
Quick Ratio: 0.8

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 9.2

AMRX Technical Analysis vs Fundamental Analysis

Buy
54
Amneal Pharmaceuticals (AMRX) is a Buy

Is Amneal Pharmaceuticals a Buy or a Sell?